As attention is focussed on urgent research to find a vaccine or treatments for SARS-CoV-2, other medical research is likely to suffer due to the general disruption caused by the COVID-19 pandemic. Institutions, researchers, ethics committees and sponsors are receiving guidance on contingency planning and how they might manage the potential impacts of COVID-19 on ...
Clinical trials stall as COVID-19 deters clinician-patient contact
By Mardi Chapman
30 Mar 2020